Skip to main content
Journal of Veterinary Internal Medicine logoLink to Journal of Veterinary Internal Medicine
. 2019 Sep 12;33(5):2257–2266. doi: 10.1111/jvim.15620

Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome

Allison J Stewart 1,2,3,, Eileen Hackett 4, Francois‐Rene Bertin 1, Taylor J Towns 2
PMCID: PMC6766528  PMID: 31512777

Abstract

Background

Plasma adrenocorticotropic hormone (ACTH) and serum cortisol concentrations increase with illness‐associated stress. Dynamics of plasma ACTH and serum cortisol concentrations in adult horses with systemic illness are undocumented.

Hypothesis/Objective

To determine whether ACTH and cortisol concentrations and the ACTH/cortisol ratio vary with survival, the presence of systemic inflammatory response syndrome (SIRS), or ischemic gastrointestinal lesions at admission, or throughout hospitalization.

Animals

One hundred fifty‐one adult horses.

Methods

Prospective study measuring serum cortisol and plasma ACTH at admission and on days 2, 4, and 6 of hospitalization. Horses were grouped by outcome (survival, SIRS status, number of SIRS criteria [SIRS score], SIRS severity group, and the presence of an ischemic lesion). Differences between groups and over time for ACTH, cortisol, and ACTH/cortisol ratio were investigated with a mixed effect model. Receiving operator characteristic curves and odds ratios were calculated for survival and ischemia.

Results

In all groups, ACTH, cortisol, and ACTH/cortisol ratio significantly decreased over time (P < .0001). ACTH, cortisol, and ACTH/cortisol ratio were higher at admission in nonsurvivors, and ACTH and cortisol were higher in horses with ischemic lesions (P < .01). Horses with ACTH above reference interval at admission were 6.10 (2.73‐13.68 [95% confidence interval]) times less likely to survive (P < .0001). No significant difference in ACTH, cortisol, and ACTH/cortisol ratio between horses with different SIRS status, scores, or groups were detected, although nonsurvivors had a higher SIRS score (P < .0001).

Conclusions and Clinical Importance

Pituitary and adrenal responses are altered in nonsurviving horses and those with an ischemic gastrointestinal lesion.

Keywords: adrenal, CIRCI, colic, endocrinology, equine


Abbreviations

ACTH

adrenocorticotropic hormone

CIRCI

critical illness‐related corticosteroid insufficiency

CRH

corticotrophin‐releasing hormone

HPA

hypothalamic‐pituitary‐adrenal gland

ICU

intensive care unit

OR

odds ratio

PPID

pituitary pars intermedia dysfunction

ROC

receiver operating characteristic

SIRS

systemic inflammatory response syndrome

1. INTRODUCTION

The hypothalamic‐pituitary‐adrenal (HPA) axis is the major neuroendocrine pathway involved in the homeostatic response to the stress of illness.1 Increasing circulating concentrations of corticotrophin‐releasing hormone (CRH), arginine vasopressin, ACTH, cortisol, and aldosterone are essential components of the stress response and are typically proportional to the magnitude of the injury or disease process.1 The systemic effects of cortisol are important in the homeostatic response to illness, including maintenance of blood pressure, provision of cellular nutrients, and moderation of inflammation.

Although cortisol and ACTH concentrations are expected to be high during acute illness, basal and ACTH‐stimulated cortisol concentrations lower than expected for the degree of illness have been identified in critically ill human patients and foals.2, 3, 4, 5 Although absolute hypoadrenocorticism is rare in intensive care unit (ICU) patients, relative adrenal insufficiency (RAI) is the most easily diagnosed cause of critical illness‐related corticosteroid insufficiency (CIRCI).5 This complex syndrome might also be because of inadequate CRH or ACTH production, or peripheral tissue resistance to cortisol.5 In human ICU patients, CIRCI is commonly caused by systemic inflammatory response syndrome (SIRS) and sepsis.5, 6 Inflammatory mediators released in response to illness can suppress CRH and ACTH secretion, thereby leading to impairment of cortisol synthesis.5, 6 Inflammatory cytokines such as tumor necrosis factor‐α, interleukin‐1, and interleukin‐6 can cause ACTH resistance and alter cortisol secretion and metabolism, which can result in a normal to high ACTH concentration and an inappropriately low cortisol concentration.6, 7 Inadequate cortisol production for the increased demands of critical illness can result in hypotension, hemodynamic instability, excessive inflammation, hypoglycemia, and nonspecific signs of depression, anorexia, and weakness.5

Cortisol has been measured in horses with colic and hospitalized foals,3, 4, 8, 9, 10, 11, 12 while ACTH has been measured in sick foals and a limited number of horses with colic.3, 4, 8, 9, 10, 12 Sparse information is available regarding endocrine function and dysfunction in sick adult horses throughout hospitalization,13, 14 but extensive adrenal gland hemorrhage, venous thrombosis, and adrenocortical necrosis are common findings in horses with ischemic gastrointestinal lesions at necropsy,15 providing a structural basis for development of RAI/CIRCI. Although incompletely understood, recognition and treatment of CIRCI in humans has improved survival rates, especially in the management of shock and sepsis.16, 17 A high ACTH/cortisol ratio was initially used in neonatal foals to diagnose hypothalamic‐adrenal dysregulation, indicating adrenal exhaustion, adrenal damage, or inadequate cortisol production and release in response to high pituitary output of ACTH.3, 12 In septic foals, nonsurvivors had significantly higher ACTH/cortisol ratios than did surviving foals, suggesting possible CIRCI in those nonsurvivors.3, 12 Relative adrenal insufficiency/CIRCI has been diagnosed by an inadequate cortisol response to exogenously administered ACTH or a low basal cortisol concentration in humans and foals.5, 8, 9

The overall objective was to describe ACTH and cortisol dynamics in spontaneously sick adult horses by evaluation of their associations with survival, SIRS, and the presence of ischemic gastrointestinal lesions. We hypothesized that cortisol and ACTH would be increased in proportion to illness severity, but a proportion would have HPA dysregulation with high ACTH/cortisol ratio. We expected that ACTH and cortisol concentrations would rapidly return to reference ranges in mildly ill horses, but might remain high in severely ill horses.

2. MATERIALS AND METHODS

2.1. Data collection

Horses (>1 year of age) presenting to the emergency service of 2 university teaching hospitals were recruited over 2 summers (mid‐May until mid‐August). Serum cortisol and plasma ACTH concentrations were measured at admission (before hospital administration of any medication) and on days 2, 4, and 6 if the horse was still hospitalized. A validated classification of SIRS was based on the presence of ≥2 of the following criteria: hypothermia (<37.0°C or 98.6°F), hyperthermia (>38.5°C or 101.3°F), tachypnea (respiratory rate > 20 breaths/min), tachycardia (heart rate > 52 beats/min), leukocytosis (white cell count >12 500/μL), leukopenia (white cell count <5000/μL), or the presence of > 10% band neutrophils.18 Horses were then assigned a SIRS score based on the number of SIRS criteria identified at admission (SIRS 0‐SIRS 4).18 Horses were then assigned into 3 groups: non‐SIRS (SIRS score 0 and 1); SIRS 2 (SIRS score 2 cases); and SIRS 3/SIRS 4 (SIRS 3 and 4 cases).18 Horses with clinical signs or a history associated with pituitary pars intermedia dysfunction (PPID) such as hypertrichosis, abnormal shedding, polyuria/polydipsia, or laminitis were excluded. Any case euthanized because of financial limitations without a poor prognosis was excluded.

Data recorded included signalment, physical examination findings, and routine bloodwork at admission (hematological and biochemical data), diagnosis, outcome, duration of hospitalization, and the presence of an ischemic gastrointestinal lesion for horses that underwent surgery or necropsy. Blood was collected by either venipuncture or an aseptically placed intravenous catheter and placed in a plain tube and a cold tube containing EDTA mixed with 0.3 mL of the protease inhibitor aprotinin (aprotinin lyophilized powder, USB Corp, Cleveland, OH) with final concentration: 500 kallikrein inactivator units/mL of blood. Blood was allowed to clot for 45 minutes at room temperature and centrifuged to collect serum, while plasma was centrifuged within 20 minutes. Samples were frozen at −80°C until assayed. Endogenous serum total cortisol and plasma ACTH concentrations (hereafter referred to as “cortisol” and “ACTH”) were measured in duplicate using radioimmunoassays (Coat‐A‐Count Cortisol In‐vitro Diagnostic Test Kit, Diagnostic Products Corporation, Los Angeles, CA; ACTH Immunoradiometric assay, Scantibodies Laboratory Inc, Santee, CA) previously validated in horses.19, 20 Intra‐ and interassay coefficients of variation were <15% and <19%, respectively, for ACTH, with upper limit of the laboratory interval <28 pg/mL.20, 21 The interassay and intra‐assay coefficients of variation for the cortisol assay ranged from 7.1% to 7.7% and from 6.1% to 8.1%, respectively.19 Laboratory reference range for cortisol concentration was 1.49‐6.45 μg/dL.21 All aspects of the study were approved by the universities’ Institutional Laboratory Animal Care and Use Committees.

2.2. Data analysis

Horses were categorized based on survival (discharged alive or not), the presence of SIRS (≥2 SIRS criteria), the number of SIRS criteria (SIRS score), SIRS group, and the presence of an ischemic lesion and compared. For continuous data, normality was assessed by a Shapiro‐Wilk normality test. No data followed a normal distribution; therefore, all were reported as median [range], as were ordinal data. Admission SIRS scores were compared between groups using a Mann‐Whitney test. Nominal data were reported as counts and percentage of horses in which the variable was documented. Counts were compared using either a Chi‐square test or a Fisher's exact test depending on expected counts. Odds ratios (OR) and 95% confidence intervals (CI) were calculated when appropriate. A linear mixed effect model determined the effect of survival, SIRS, SIRS score, SIRS group, or ischemia and time on ACTH, cortisol, and ACTH/Cortisol. Sidak's multiple comparisons test was used for post hoc analysis. A receiver operating characteristic (ROC) curve was plotted to analyze the prognostic value of a given variable (ACTH, cortisol, or ACTH/cortisol ratio) at admission for predicting survival, the presence of SIRS, or an ischemic lesion. The cutoff value was selected to optimize sensitivity and likelihood ratio. Commercially available statistical software was used (Prism, GraphPad Software, Inc. La Jolla, CA). P < .05 was considered statistically significant.

3. RESULTS

3.1. Animal population

One hundred fifty‐one horses were included and ranged from 1 to 34 years of age with a median age of 11 years. Fifty‐nine horses (39%) were female and 92 (61%) were male including 82 geldings (89% of males) and 10 stallions (11% of males). Breeds included Quarter Horses and associated breeds (60 horses, 40%), Tennessee Walking horses/Saddlebreds (22 horses, 14%), Thoroughbreds (18 horses, 12%), Warmbloods (16 horses, 11%), Arabians (12 horses, 8%), draft horses (8 horses, 6%), ponies (7 animals 5%) and mixed, and other breeds (8 horses, 6%), reflecting the hospital populations.

3.2. Clinical data

The most common clinical signs reported were tachycardia (82 horses, 55%), tachypnea (67 horses, 46%), prolonged capillary refill time (42 horses, 28%), hypothermia (25 horses, 17%), and pyrexia (18 horses, 7%). Dehydration was recorded in 93/131 horses (71%) with a median estimation of 6% (4‐12). Nasogastric reflux was present in 33/127 horses (26%) with a median volume of 7 L (2‐19). Rectal palpation was performed in 134/151 horses (89%) and in 110 horses (82%) abnormal findings were described. The most commonly reported abnormal findings were distention of small intestine (48 horses, 43%), large colon impaction (26 horses, 17%), and large colon displacement (37 horses, 25%). A complete blood count was available in 134 horses (89%) and a serum chemistry profile was available in 107 horses (71%). The most commonly reported abnormalities were hyperglycemia (62/109 horses, 57%), neutrophilia (79/134, 59%), hypokalemia (55/107, 51%), hyperlactatemia (27/55, 49%), hyponatremia (51/107, 48%), low base excess (21/48, 44%), low ionized calcium (20/52, 38%), hyperfibrinogenemia (28/91, 31%), hypoalbuminemia (25/84, 30%), increased creatinine (32/131, 24%), leukocytosis (27/134, 20%), decreased bicarbonate (20/103, 19%), leukopenia (20/134, 15%), and neutropenia (19/134, 14%).

The final diagnosis involved the gastrointestinal system in 144 horses (97), the respiratory system in 3 horses (2%), and the reproductive system and the neurologic system in 1 case each (<1% each). Forty‐five horses with a gastrointestinal disease (31%) had an explorative celiotomy and, based on surgery (27 horses) or necropsy reports (23 horses), 50 (33%) had an ischemic lesion. One hundred six horses (70%) were discharged alive. No horses died spontaneously, but 45 horses were euthanized as the attending specialist advised the prognosis was poor to hopeless. Thirty cases were euthanized either at admission or during the first evening (4 of which had ruptured bowel at admission and 4 additional cases were euthanized during exploratory celiotomy). Of the 6 nonsurvivors that lived 6 or more days, only 4 were sampled on every occasion. Of the nonsurvivors, 32/45 (71%) had SIRS, whereas 44/106 (41%) survivors had SIRS. The median SIRS score in nonsurvivors was significantly higher than in survivors (2 [0‐4] versus 1 [0‐4], P < .0001). The survival rates for each of the SIRS scores and groups are shown in Table 1.

Table 1.

Distribution of survivors and nonsurvivors between SIRS scores 0‐4 and SIRS groups, SIRS 0/SIRS 1, SIRS 2, and SIRS 3/SIRS 4

Survivors (106) Nonsurvivors (45)
SIRS 0 26 62 62 (59%) 1 13 13 (29%)
SIRS 1 36 12
SIRS 2 30 30 44 (41%) 14 14 32 (71%)
SIRS 3 10 14 11 18
SIRS 4 4 7

4. SURVIVAL

4.1. Adrenocorticotropic hormone

There was a significant effect of time and survival status on ACTH concentration, with higher ACTH concentrations at admission overall (P = .006) and in nonsurvivors (P = .009). In survivors, ACTH concentrations on day 2 were significantly higher than on day 6 (P = .021). At admission, ACTH concentrations were significantly higher in nonsurvivors than in survivors (P = .009, Figure 1A and Table S1).

Figure 1.

Figure 1

A‐C, Plasma adrenocorticotropic hormone (ACTH, A), serum cortisol (B), and ACTH/cortisol ratio (C) at admission, day 2, day 4, and day 6 of hospitalization in survivors (solid circles) versus nonsurvivors (hollow circles). *Difference between survivors and nonsurvivors for ACTH (P < .0009), cortisol (P = .012), and ACTH/cortisol ratio (P = .0001). The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

Of the surviving horses, 86% (71/83) had an ACTH concentration within the reference range at admission, whereas 49% of horses (32/65) with ACTH outside the reference range survived. The proportion of horses with ACTH concentrations below reference range for each day of hospitalization is shown in Table 2. Of the surviving horses, 92% (95/103) had a normal ACTH concentration before hospital discharge. When the ACTH concentration was outside the reference range at admission the OR and 95% CI for nonsurvival was 6.10 (2.73‐13.68), P < .0001. The ROC curve showed that a plasma ACTH concentration > 30.5 pg/mL (the algorithm's suggested optimal cutoff) was a fair diagnostic test to predict survival with an area under the ROC of 0.75, with sensitivity of 71.1% (95% CI = 55.7‐83.6) and specificity of 71.8% (62.1‐80.3) and a likelihood ratio of 2.53 for nonsurvival (P < .0001). On day 2, 91.2% of horses (62/68) with ACTH within reference range survived, while 68.6% of horses (11/16) with ACTH outside reference range survived. For ACTH concentration outside reference range on day 2, the OR for nonsurvival was 4.70 (1.26‐15.54), P = .016.

Table 2.

Proportion of horses with ACTH below the laboratories reference range of <28 pg/mL on each day of hospitalization

Proportion of horses with ACTH <28 pg/mL Day 0 Day 2 Day 4 Day 6
All horses 83/148 = 56.1% 68/84 = 80.9% 43/50 = 86% 25/29 = 86.2%
Surviving horses 71/103 = 68.9% 62/73 = 84.9% 40/45 = 88.9% 23/25 = 92%
Nonsurviving horses 12/45 = 26.7% 6/11 = 54.5% 3/5 = 60% 2/4 = 50%

4.2. Cortisol

There was a significant effect of time and survival status on cortisol concentration with higher cortisol at admission overall (P < .0001) and in nonsurvivors (P = .011). In survivors, cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P < .0001, for all comparisons), on day 2 compared to day 6 (P < .0001), and on day 4 compared to day 6 (P = .0006). In nonsurvivors, cortisol concentrations at admission were significantly higher than on day 4 (P = .0061). At admission, cortisol concentrations were significantly higher in nonsurvivors than in survivors (P = .011, Figure 1B and Table S1).

The ROC curve showed that a serum cortisol concentration >11.7 μg/dL was a poor diagnostic test to predict survival with an area under the ROC of 0.68, with sensitivity of 68.9% (95% CI = 53.4‐81.8), specificity of 67.3% (57.4‐76.2; P = .0004), and a likelihood ratio of 2.11 for nonsurvival.

4.3. ACTH/cortisol ratio

There was no significant effect of time on ACTH/cortisol (P = .6801); however, there was a significant effect of survival (P = .0001). At admission, ACTH/cortisol ratios were significantly higher in nonsurvivors than in survivors (P = .0001, Figure 1C and Table S1).

The ROC curve showed that an ACTH/cortisol ratio concentration > 2.6 was a poor diagnostic test to predict survival with an area under the ROC of 0.696, with sensitivity of 64.4 (95% CI = 48.8‐78.1), specificity of 67.3% 67.3 (57.3‐76.3) and a likelihood ratio of 1.97 for nonsurvival (P = .0002).

5. SIRS SCORES AND GROUPS

5.1. Adrenocorticotropic hormone

5.1.1. SIRS versus no SIRS

There was a significant effect of time on ACTH concentrations with higher ACTH concentrations at admission (P = .008); however, there was no effect of having SIRS (P = .57). In horses with no SIRS, ACTH concentrations at admission were significantly higher than on day 6 (P = .006). In horses with SIRS, ACTH concentrations at admission were significantly higher than on days 2 and 4 (P = .048 and .0032, respectively, Figure 2A and Table S2).

Figure 2.

Figure 2

A‐C, Plasma adrenocorticotropic hormone (ACTH, A), serum cortisol (B), and ACTH/cortisol ratio (C) at admission, day 2, day 4, and day 6 of hospitalization for horses with systemic inflammatory response syndrome (SIRS, hollow circles) verses without SIRS (solid circles). The presence of SIRS is defined as having ≥2 SIRS criteria which are defined as: heart rate >52 bpm, respiratory rate >20 bpm, temperature below or above 37.0–38.5°C, and WBC below or above 5.0–12.5 × 109/L (or the presence of band neutrophils). The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

5.1.2. SIRS scores

There was a significant effect of time on ACTH concentrations with higher ACTH concentrations at admission (P = .036); however, there was no effect of SIRS score (P = 0.94). In horses with a SIRS score of 1, ACTH concentrations were significantly higher at admission than on day 6 (P = .021) and on day 2 compared to days 4 and 6 (P = 0.024 and 0.029, respectively, Figure S1A and Table S3).

5.1.3. SIRS groups

There was a significant effect of time on ACTH concentrations with higher ACTH concentrations at admission (P = .013); however, there was no effect of SIRS group (P = .80). In horses without SIRS (SIRS 1/SIRS 0), ACTH concentrations were significantly higher at admission than on day 6 (P = .005) and on day 2 compared to day 6 (P = .039). In horses with SIRS 3/SIRS 4, ACTH concentrations at admission were significantly higher than on day 4 (P = .013, Figure S2A and Table S4).

5.2. Cortisol

5.2.1. SIRS versus no SIRS

There was a significant effect of time on cortisol concentrations with higher cortisol concentrations at admission (P < .0001); however, there was no effect of having SIRS (P = .41). In horses with no SIRS, cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P < .0001 for all comparisons) and on day 2 compared to day 6 (P = .0356). In horses with SIRS, cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P < .0001 for all comparisons); on day 2 compared to days 4 and 6 (P = .0237 and <.0001, respectively) and on day 4 compared to day 6 (P = .0382, Figure 2B and Table S2).

5.2.2. SIRS scores

There was a significant effect of time on cortisol concentrations with higher cortisol concentrations at admission (P < .0001); however, there was no effect of SIRS score (P = .85). In horses with a SIRS score of 0, cortisol concentrations at admission were significantly higher than on day 2, 4, and 6 (P = .005, .027, and .041, respectively). In horses with a SIRS score of 1, cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P = .004, .0004, and .0002, respectively), on day 2 than day 6 (P = .0005), and on day 4 than day 6 (P = .0075). In horses with a SIRS score of 2, cortisol concentrations at admission were significantly higher than on days 2, 4, and 6 (P = .005, .0009, and .024, respectively). In horses with a SIRS score of 3, cortisol concentrations at admission were significantly higher than on days 2 and 4 (P = .002 and .0002, respectively, Figure S1B and Table S3).

5.2.3. SIRS groups

There was a significant effect of time on cortisol concentrations with higher cortisol concentrations at admission (P < .0001); however, there was no effect of SIRS group (P = .68). In horses without SIRS (SIRS 1/SIRS 0), cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P < .0001 for all comparisons); on day 2 compared to days 4 and 6 (P = .019 and <.0001) and on day 4 compared to day 6 (P = .029). In horses with SIRS 2, cortisol concentrations at admission were significantly higher than on days 2, 4, and 6 (P = .004, .0007, and .022, respectively). In horses with SIRS 3/SIRS 4, cortisol concentrations at admission were significantly higher than on days 2, 4, and 6 (P < .0001, .0002, and .009, respectively, Figure S2B and Table S4).

5.3. ACTH/cortisol ratio

5.3.1. SIRS versus no SIRS

There was no significant effect of time or having SIRS on ACTH/cortisol ratio (P = .37 and .22, respectively, Figure 2C and Table S2).

5.3.2. SIRS scores

There was no significant effect of time or SIRS score on ACTH/cortisol ratio (P = .51 and .46, respectively, Figure S1C and Table S3).

5.3.3. SIRS group

There was no significant effect of time or SIRS group on ACTH/cortisol ratio (P = .41 and .16, respectively, Figure S2C and Table S4).

6. ISCHEMIC GASTROINTESTINAL LESIONS

Of the 50 horses with ischemic lesions, only 36% (18/50) survived, while 87.1% (88/101) with nonischemic lesions survived. Horses with an ischemic lesion were 12 times more likely not to survive (OR: 12.03 [5.36‐25.54], P < .0001). Median SIRS score in horses with an ischemic lesion was significantly higher than in horses with no ischemic lesion (2 [0‐4] versus 1 [0‐4], P = .025).

6.1. Adrenocorticotropic hormone

There was a significant effect of time and ischemia on ACTH concentrations with higher ACTH concentrations overall at admission (P = .0008) and in horses with an ischemic lesion (P = .008). In horses with no ischemic lesion, ACTH concentrations were significantly higher at admission than on day 4 (P = .0003) and on day 2 compared to day 6 (P = .038). In horses with an ischemic lesion, ACTH concentrations were significantly higher at admission than on day 6 (P = .013). At admission, horses with an ischemic lesion had significantly higher ACTH concentrations than horses without (P = .006, Figure 3A and Table S5). The ROC curve showed that an ACTH concentration > 28.5 pg/mL was a poor diagnostic test to predict ischemia with an area under the ROC of 0.73, with sensitivity of 66.7% (52.1‐79.2), specificity of 69.1% (58.9‐78.1), and a likelihood ratio of 2.16 for the presence of an ischemic lesion (P < .0001).

Figure 3.

Figure 3

A‐C, Plasma adrenocorticotropic hormone (ACTH, A), serum cortisol (B), and ACTH/cortisol ratio (C) at admission, day 2, day 4, and day 6 of hospitalization in horses with ischemic gastrointestinal lesions (open circles) versus horses without ischemic lesions (full circles). *Difference between ischemic and nonischemic for ACTH (P = .0061) and cortisol (P = .0009). The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

6.2. Cortisol

There was a significant effect of time and ischemia on cortisol concentrations with higher cortisol concentrations at admission overall (P < .0001) and in horses with an ischemic lesion (P = .0007). In horses with no ischemic lesion, cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P < .0001, .0001, and .001, respectively), on day 2 compared to day 6 (P = .002) and on day 4 to day 6 (P = .019). In horses with an ischemic lesion, cortisol concentrations were significantly higher at admission than on days 2, 4, and 6 (P = .0006, .0001 and .0001, respectively), on day 2 compared to days 4 and 6 (P = .0011 and .0002, respectively). At admission, horses with an ischemic lesion had significantly higher cortisol concentrations than horses without (P = .0009, Figure 3B and Table S5).

The ROC curve showed that a cortisol concentration > 11.6 μg/dL was a poor diagnostic test to predict ischemia with an area under the ROC of 0.73, with sensitivity of 70.6% (56.2‐82.5), specificity of 69.4% (59.3‐78.3) and a likelihood ratio of 2.31 for the presence of an ischemic lesion (P < .0001).

6.3. ACTH/cortisol ratio

There was no significant effect of time or the presence of an ischemic lesion on ACTH/cortisol ratio (P = .23 and .21, respectively, Figure 3C and Table S5). The ROC curve showed that an ACTH/cortisol ratio > 2.4 was a poor diagnostic test to predict ischemia with an area under the ROC of 0.63, with sensitivity of 62.8% (48.1‐75.9), specificity of 64.2% (53.7‐73.8) and a likelihood ratio of 1.75 for the presence of an ischemic lesion (P = .0071).

7. DISCUSSION

Cortisol and ACTH concentrations were higher in nonsurviving horses and those with an ischemic gastrointestinal lesion. The ACTH/cortisol ratio was higher in nonsurviving horses. When ACTH concentrations were within reference range on admission or day 2, horses had 6.1 or 4.2 times higher likelihood of survival. The ideal ACTH cutoff value for predicting survival was > 30.5 pg/mL, with a sensitivity and specificity of only 71% and 72%. Cortisol was a poorer predictor of survival, where a cutoff value of > 11.7 μg/dL had sensitivity and specificity of 69% and 67%. Therefore, ACTH and cortisol concentrations should not be used as sole predictors of survival. Although the pituitary gland has a high capacity to increase ACTH production, in surviving animals this response was rapidly normalized, with 92% of horses having ACTH within reference interval before hospital discharge. Overall, both ACTH and cortisol decreased over time and the effect was more marked in nonsurvivors. Although the SIRS score was higher in nonsurvivors and horses with ischemia, there was no effect of SIRS status, SIRS score, or SIRS groups on ACTH, cortisol, or ACTH/cortisol ratio.

Several scoring systems have been compared to categorize the severity of illness and likelihood of survival in septic foals, allowing comparison between research studies.22, 23 There is no accepted grading scheme to categorize the severity of illness in adult horses, although a scoring system for multiple organ dysfunction in equine surgical patients was recently developed.24 An equine SIRS score validated using a primary referral practice had a SIRS rate of 31.3% of all emergency admissions, 24% of colic cases, and 67% of horses with a strangulating gastrointestinal lesion.18 In our study, SIRS was diagnosed in 50% of horses, 58% of colics with ischemic lesions, and 71% of nonsurvivors. The diagnostic utility of this SIRS score was improved with the addition of blood lactate and mucous membrane color.18 A colic severity score utilizing heart rate, peritoneal fluid total protein, and blood lactate had a 93% accuracy at predicting survival.25 Unfortunately, blood lactate concentration was available for less than half of our horses, and peritoneal fluid total protein for 60% of cases.

In critically ill humans, the APACHE‐II score assesses illness severity and risk of death.26 However, day 2 cortisol concentration was a better discriminator of ICU patient outcome with a predictive ability of 81%, while the APACHE‐II score had a predictive ability of only 70%.27, 28 Although ACTH, cortisol, and ACTH/cortisol ratios were higher in our nonsurvivors, no single factor should be used to predict survival of individual cases. Experienced equine clinicians are also better predictors of survival than scoring systems.29 Although many studies have investigated admission clinicopathologic findings to assess likelihood of survival, changes over time, in horses surviving the initial admission period, might be more important. We attempted to assess cortisol and ACTH concentrations over 6 days of hospitalization, but many nonseverely ill horses were discharged before day 6, and the majority of our nonsurvivors were euthanized within the initial 24 hours, with only 11 nonsurvivors available for testing on day 2, which was underpowered to show a difference between survivors and nonsurvivors.

Equine emergency patients experience stress from fear, pain, dehydration, inappetence, and consequences of systemic inflammation such as fever, hypotension, or hypoxemia. Factors affecting CRH secretion in a variety of species include cytokines, lipopolysaccharide, brain‐derived neurotropic factor, neurosteroids, glutamate, γ‐aminobutyric acid, nitric oxide, and glucocorticoids (through negative feedback).30 Lipopolysaccharide was detected in 29% of horses presenting for colic, and is more commonly detected in horses with ischemic gastrointestinal lesions.31 Interleukins‐1β, ‐6, and ‐8 mRNA expression have been shown to be upregulated in surgical colic patients.32 Neurosteroids have been measured in critically ill foals, but effects of inflammatory mediators on the HPA axis of sick horses has not been investigated. Arginine vasopressin and CRH stimulate ACTH release from corticotropes in the pituitary pars distalis, which is moderated by cytokines, lipopolysaccharide, nitric oxide, and glucocorticoids during illness.30 We did not assess CRH or vasopressin concentrations but the prevalence of ACTH hyposecretion or hypothalamic dysregulation in relation to HPA axis dysfunction appears a rare cause of CIRCI compared to adrenocortical failure in humans and septic foals.4, 5

Studies assessing ACTH concentrations in sick adult horses are sparse, with mean ACTH concentration 2.4 times higher in 43 horses with colic compared to normal controls, with highest values in horses with strangulated intestine.10 Similarly, we found ACTH was significantly higher (3.4 times) in horses with ischemic gastrointestinal lesions than those without. Median ACTH in nonsurviving horses was 3.6 times higher than normal horses (from our institution measured with the same assay20). However, individual variation in sick horses was extreme, with the highest ACTH occurring in a surviving horse, which was 49 times higher than normal horses. In comparison to adult horses, foals have lower ACTH concentrations and ACTH is higher in septic compared to healthy foals and higher in nonsurvivors than survivors.3, 4, 33, 34

The adrenal cortex zona fasciculata secretes glucocorticoids (cortisol), which decrease CRH, vasopressin, and ACTH secretion by negative feedback. Cortisol increases gluconeogenesis, decreases glucose utilization, increases serum glucose, and inhibits the effects of insulin. Median cortisol was increased in nonsurvivors and those with ischemic gastrointestinal lesions. These findings were supported by previous studies in horses with colic.10, 35 Mair showed that cortisol > 7.25 μg/dL was more common in horses with colic than healthy controls; that cortisol was higher in horses with colic with a heart rate > 45 beats per minute, and that a higher cortisol was associated with more severe signs of colic.11 This study was unable to detect a direct association between high cortisol and non‐survival.11

We were expecting disease severity, as defined by SIRS status/score/group to significantly affect ACTH and cortisol concentrations, but this was not identified. The original SIRS definitions were intended to identify human patients with severe disease.36 Other scoring systems such as the APACHE‐II are designed to grade disease severity.37 Although SIRS status, scores, or groups are useful to differentiate horses with and without systemic illness,14, 18 horses without systemic illness (wounds, fractures, and ocular emergencies), were not included in our study. Although illness severity was higher, the spread of severities in our study population was less than the primary referral equine SIRS validation study.18 Alternatively, the reason that we failed to find associations with SIRS status/score/group in comparison to hormone concentrations might be caused by CIRCI. A subset of critically ill horses with inappropriately low endogenous cortisol would cancel out appropriately high cortisol concentrations during statistical analysis. In a separate smaller study in which ACTH stimulation tests were performed on systemically ill horses, we determined that cortisol <4.51 μg/dL was inappropriately low38 (mean − 1 standard deviation obtained from healthy horses).34, 39 With this cutoff in the current study, 11/149 (7.4%) of horses would have inappropriately low cortisol at admission, 19/90 (21.1%) on day 2, 16/55 (29.1%) on day 4, and 19/31 (61.3%) on day 6. Regardless of illness severity, sick hospitalized horses should not have a cortisol concentration less than that of stall acclimatized, university‐owned teaching horses.

Basal cortisol is lower in normal neonatal foals than adult horses, but adult horses have greater adrenal reserve with increased cortisol release after exogenous ACTH stimulation.33, 34 Our sick adult horses had higher cortisol concentrations than those observed in septic neonatal foals.3, 4

When pituitary reserve and ability to release ACTH exceeds the corresponding capacity for adrenal production and release of cortisol, a high ACTH/cortisol ratio results indicating ACTH‐cortisol imbalance.12, 14 Adrenal gland dysfunction or RAI/CIRCI is identified when cortisol release is inadequate for illness severity. Although ACTH/cortisol ratio is not a criteria for the diagnosis of CIRCI in humans, and is not as accurate as an ACTH stimulation test,4, 5 it is easily performed, inexpensive and has provided useful information in critically ill foals.3, 8, 9 We found a higher ACTH/cortisol ratio in nonsurvivors, while others have found higher ACTH/cortisol ratios in septic compared to sick‐nonseptic or normal foals.3, 12 The value is much higher in foals because healthy and sick foals have higher ACTH and lower cortisol than adult horses.33, 34 In a small study of 10 horses with SIRS, nonsurvivors had an increased (but not statistically significant) ACTH/cortisol ratio and a decrease in glucocorticoid receptor binding affinity, which suggests tissue resistance to glucocorticoids.14

An appropriate cortisol concentration in response to illness of varying severities has not been defined for adult horses. In humans and foals, a low baseline cortisol concentration or an inadequate response to a high‐ or low‐dose ACTH stimulation test have been advocated as means to diagnose CIRCI.5, 8, 9 However, in human medicine, because of the low sensitivity and specificity of the results of endocrine testing to diagnose CIRCI, current recommendations are to administer low‐dose corticosteroids to treat adult patients with septic shock that are nonresponsive to fluid therapy or moderate to high doses of vasopressors rather than waiting on endogenous or ACTH‐stimulated cortisol test results.5

This study could have been improved by a larger sample size and serial assessments of blood pressure and lactate and adrenal and pituitary histopathology on all nonsurvivors. Overall, higher concentrations of ACTH, cortisol, and ACTH/cortisol ratio were associated with nonsurvival and higher ACTH and cortisol with the presence of an ischemic lesion. There was a subset of horses with inappropriately low cortisol suggesting the presence of RAI/CIRCI. Inflammation, shock, ischemia/reperfusion injury, and SIRS are common syndromes requiring multimodal medical treatment in horses with colic. Inappropriately low basal cortisol concentrations, especially with a high ACTH/cortisol ratio could indicate pituitary‐adrenal dysregulation and possible RAI/CIRCI.3, 14 This requires further investigation in severely ill horses in conjunction with assessment of ACTH‐stimulated cortisol concentrations before treatment is considered.

CONFLICT OF INTEREST DECLARATION

Authors declare no conflict of interest.

OFF‐LABEL ANTIMICROBIAL DECLARATION

Authors declare no off‐label use of antimicrobials.

INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) OR OTHER APPROVAL DECLARATION

All aspects of the study were approved by the Auburn and Colorado State Universities Institutional Laboratory Animal Care and Use Committees (2009‐1564, 09‐079A‐01) and the College of Veterinary Medicine Clinical Research Review Committee. Signed owner's consent was obtained for all procedures.

HUMAN ETHICS APPROVAL DECLARATION

Authors declare human ethics approval was not needed for this study.

Supporting information

FIGURE S1A‐C, Plasma ACTH (A), serum cortisol (B), and ACTH/cortisol ratio (C) at admission, day 2, day 4, and day 6 of hospitalization in horses with SIRS scores 0‐4. The SIRS score is based on the number of abnormal SIRS criteria based on heart rate > 52 bpm, respiratory rate > 20 bpm, temperature below or above 37.0‐38.5°C, and WBC below or above 5.0‐12.5 × 109/L. From right to left on each day SIRS score 0 (SIRS0), SIRS1, SIRS2, SIRS3, and SIRS4. The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

FIGURE S2A‐C, Plasma ACTH (A), serum cortisol (B), and ACTH/cortisol ratio (c) at admission, day 2, day 4, and day 6 of hospitalization in horses with no SIRS (0‐1 abnormal criteria); SIRS2: 2 abnormal SIRS criteria; SIRS 3/SIRS 4:3 or 4 abnormal SIRS criteria. The SIRS criteria are defined as: heart rate > 52 bpm, respiratory rate > 20 bpm, temperature below or above 37.0–38.5°C, and WBC below or above 5.0‐12.5 × 109/L. From right to left on each day SIRS0, SIRS1/2, and SIRS 3/SIRS 4. The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

Table S1. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol ratio for survivors and nonsurvivors over 6 days of hospitalization

Table S2. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol for horses with and without SIRS over 6 days of hospitalization

Table S3. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol ratio for SIRS score categories (0‐4) over 6 days of hospitalization

Table S4. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol ratio for horses with no SIRS (0‐1 abnormal criteria); SIRS2: 2 abnormal SIRS criteria; SIRS 3/SIRS 4:3 or 4 abnormal SIRS criteria over 6 days of hospitalization

Table S5. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol for horses with and without an ischemic gastrointestinal lesion over 6 days of hospitalization

ACKNOWLEDGMENTS

Heather Weaver, Bradley Johnson, Rebecca Funk, Amelia Munsterman, Christina Hewes, Anne A. Wooldridge, and Erin S. Groover for assistance with enrolment of horses and sample collection, and Katherine A. Busch, Qiao Zhong for technical assistance.

Stewart AJ, Hackett E, Bertin F‐R, Towns TJ. Cortisol and adrenocorticotropic hormone concentrations in horses with systemic inflammatory response syndrome. J Vet Intern Med. 2019;33:2257–2266. 10.1111/jvim.15620

Presented in part as a research abstract at the 40th Bain Fallon Memorial Lectures, Australian Equine Veterinary Association, Sydney, July 2018.

Funding information American College of Veterinary Emergency and Critical Care research award and Morris Animal Foundation: Veterinary Student Summer Scholarship program

REFERENCES

  • 1. Munck A, Guyre PM, Holbrrok NJ. Physiologic functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev. 1984;5:25‐44. [DOI] [PubMed] [Google Scholar]
  • 2. Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill – a new look at an old problem. Chest. 2002;122:1784‐1796. [DOI] [PubMed] [Google Scholar]
  • 3. Gold JR, Divers TJ, Barton MH, et al. Plasma adrenocorticotropin, cortisol, and adrenocorticotropin/cortisol ratios in septic and normal‐term foals. J Vet Intern Med. 2007;21:791‐796. [DOI] [PubMed] [Google Scholar]
  • 4. Hurcombe SDA, Toribio RE, Slovis N, et al. Blood arginine vasopressin, adrenocorticotropin hormone, and cortisol concentrations at admission in septic and critically ill foals and their association with survival. J Vet Intern Med. 2008;22:639‐647. [DOI] [PubMed] [Google Scholar]
  • 5. Annane D, Pastores SM, Rochwerg B, et al. Guidelines for the diagnosis and management of critical illness‐related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017 (vol 43, pg 1751, 2017). Intensive Care Med. 2018;44:401‐402. [DOI] [PubMed] [Google Scholar]
  • 6. Zaloga GP, Marik P. Hypothalamic‐pituitary‐adrenal insufficiency. Crit Care Clin. 2001;17:25‐41. [DOI] [PubMed] [Google Scholar]
  • 7. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348:727‐734. [DOI] [PubMed] [Google Scholar]
  • 8. Wong DM, Vo DT, Alcott CJ, Peterson AD, Sponseller BA, Hsu WH. Baseline plasma cortisol and ACTH concentrations and response to low‐dose ACTH stimulation testing in ill foals. J Am Vet Med Assoc. 2009;234:126‐132. [DOI] [PubMed] [Google Scholar]
  • 9. Hart KA, Slovis NM, Barton MH. Hypothalamic‐pituitary‐adrenal axis dysfunction in hospitalized neonatal foals. J Vet Intern Med. 2009;23:901‐912. [DOI] [PubMed] [Google Scholar]
  • 10. Ayala I, Martos NF, Silvan G, Gutierrez‐Panizo C, Clavel JG, Illera JC. Cortisol, adrenocorticotropic hormone, serotonin, adrenaline and noradrenaline serum concentrations in relation to disease and stress in the horse. Res Vet Sci. 2012;93:103‐107. [DOI] [PubMed] [Google Scholar]
  • 11. Mair TS, Sherlock CE, Boden LA. Serum cortisol concentrations in horses with colic. Vet J. 2014;201:370‐377. [DOI] [PubMed] [Google Scholar]
  • 12. Dembek KA, Timko KJ, Johnson LM, et al. Steroids, steroid precursors, and neuroactive steroids in critically ill equine neonates. Vet J. 2017;225:42‐49. [DOI] [PubMed] [Google Scholar]
  • 13. Bertin FR, Ruffin‐Taylor D, Stewart AJ. Insulin dysregulation in horses with systemic inflammatory response syndrome. J Vet Intern Med. 2018;32:1420‐1427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Hoffman CJ, McKenzie HC, Furr MO, et al. Glucocorticoid receptor density and binding affinity in healthy horses and horses with systemic inflammatory response syndrome. J Vet Intern Med. 2015;29:626‐635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Rosol TJ, Grone A. Endocrine Glands In: Grant MG, ed. Jubb, Kennedy & Palmer's Pathology of Domestic Animals. 6th ed. Philadelphia, PA: Elsevier Saunders; 2015:339‐340. [Google Scholar]
  • 16. Annane D, Bellissant E, Bollaert PE, et al. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;108:CD002243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Gibbison B, Lopez‐Lopez JA, Higgins JPT, et al. Corticosteroids in septic shock: a systematic review and network meta‐analysis. Crit Care. 2017;21:78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Roy MF, Kwong GPS, Lambert J, Massie S, Lockhart S. Prognostic value and development of a scoring system in horses with systemic inflammatory response syndrome. J Vet Intern Med. 2017;31:582‐592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Golland LC, Evans DL, Stone GM, et al. Plasma cortisol and beta‐endorphin concentrations in trained and over‐trained standardbred racehorses. Pflug Arch Eur J Phys. 1999;439:11‐17. [DOI] [PubMed] [Google Scholar]
  • 20. Funk RA, Stewart AJ, Wooldridge AA, et al. Seasonal changes in plasma adrenocorticotropic hormone and alpha‐melanocyte‐stimulating hormone in response to thyrotropin‐releasing hormone in normal, aged horses. J Vet Intern Med. 2011;25:579‐585. [DOI] [PubMed] [Google Scholar]
  • 21. Schreiber CM, Stewart AJ, Kwessi E, et al. Seasonal variation in results of diagnostic tests for pituitary pars intermedia dysfunction in older, clinically normal geldings. J Am Vet Med Assoc. 2012;241:241‐248. [DOI] [PubMed] [Google Scholar]
  • 22. Dembek KA, Hurcombe SD, Frazer ML, Morresey PR, Toribio RE. Development of a likelihood of survival scoring system for hospitalized equine neonates using generalized boosted regression modeling. PLoS One. 2014;9:e109212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Wong DM, Ruby RE, Dembek KA, et al. Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates. J Vet Intern Med. 2018;32:1185‐1193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. McConachie E, Giguère S, Barton MH. Scoring system for multiple organ dysfunction in adult horses with acute surgical gastrointestinal disease. J Vet Intern Med. 2016;30:1276‐1283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Furr MO, Lessard P, White NA. Development of a colic severity score for predicting the outcome of equine colic. Vet Surg. 1995;24:97‐101. [DOI] [PubMed] [Google Scholar]
  • 26. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818‐829. [PubMed] [Google Scholar]
  • 27. Jarek M, Legare E, McDermott M. Endocrine profiles for outcome prediction from the intensive care unit. Crit Care Med. 1993;21:543‐550. [DOI] [PubMed] [Google Scholar]
  • 28. Rothwell PM, Lawler PG. Prediction of outcome in intensive care patients using endocrine parameters. Crit Care Med. 1995;23:78‐83. [DOI] [PubMed] [Google Scholar]
  • 29. Rohrbach BW, Buchanan BR, Drake JM, et al. Use of a multivariable model to estimate the probability of discharge in hospitalized foals that are 7 days of age or less. J Am Vet Med Assoc. 2006;228:1748‐1756. [DOI] [PubMed] [Google Scholar]
  • 30. Dembek KA, Toribio RE. Hypothalamic‐pituitary‐adrenal axis, steroids, and neuroactive steroids In: Reed SM, Bayly WM, Sellon DC, eds. Equine Internal Medicine. St Louis, MO: Elsevier; 2018:1069‐1079. [Google Scholar]
  • 31. Senior JM, Proudman CJ, Leuwer M, et al. Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes. Equine Vet J. 2011;43:585‐591. [DOI] [PubMed] [Google Scholar]
  • 32. Epstein A, Nir E, Eyngor M, et al. Dynamics of cytokine gene transcription (TNF‐alpha, IL‐1 beta, IL‐6, IL‐8) in surgically treated colic horses by use of real‐time PCR (RT‐PCR). Isr J Vet Med. 2016;71:24‐30. [Google Scholar]
  • 33. Stewart AJ, Wright JC, Behrend EN, Martin LG, Kemppainen RJ, Busch KA. Validation of a low‐dose adrenocorticotropic hormone stimulation test in healthy neonatal foals. J Am Vet Med Assoc. 2013;243:399‐405. [DOI] [PubMed] [Google Scholar]
  • 34. Stewart AJ, Behrend EN, Wright JC, et al. Validation of a low‐dose ACTH stimulation test in healthy adult horses. J Am Vet Med Assoc. 2011;239:834‐841. [DOI] [PubMed] [Google Scholar]
  • 35. Hinchcliff KW, Rush BR, Farris JW. Relationship between serum catecholamine and cortisol concentrations in horses with colic. J Am Vet Med Assoc. 2005;227:276‐280. [DOI] [PubMed] [Google Scholar]
  • 36. Bone RC, Fisher CJ. Methylprednisalone severe sepsis study group. A controlled clinical trial of high dose methylprednisalone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653‐658. [DOI] [PubMed] [Google Scholar]
  • 37. Knaus WA, Zimmerman JE, Wagner DP, et al. APACHE ‐ acute physiology and chronic health evaluation – a physiologically based classification‐system. Critical Care Med. 1981;9:591‐597. [DOI] [PubMed] [Google Scholar]
  • 38. Stewart AJ. Endocrine Response to Illness in Sick Horses: Presence of Critically‐Illness‐Related Corticosteroid Insufficiency or Pancreatic Insufficiency in Horses Is Related to Poor Survival. Vol 138 Uppsala: Swedish University of Agricultural Sciences; 2018. [Google Scholar]
  • 39. Hart KA, Barton MH, Ferguson DC, et al. Serum free cortisol fraction in healthy and septic neonatal foals. J Vet Intern Med. 2011;25:345‐355. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

FIGURE S1A‐C, Plasma ACTH (A), serum cortisol (B), and ACTH/cortisol ratio (C) at admission, day 2, day 4, and day 6 of hospitalization in horses with SIRS scores 0‐4. The SIRS score is based on the number of abnormal SIRS criteria based on heart rate > 52 bpm, respiratory rate > 20 bpm, temperature below or above 37.0‐38.5°C, and WBC below or above 5.0‐12.5 × 109/L. From right to left on each day SIRS score 0 (SIRS0), SIRS1, SIRS2, SIRS3, and SIRS4. The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

FIGURE S2A‐C, Plasma ACTH (A), serum cortisol (B), and ACTH/cortisol ratio (c) at admission, day 2, day 4, and day 6 of hospitalization in horses with no SIRS (0‐1 abnormal criteria); SIRS2: 2 abnormal SIRS criteria; SIRS 3/SIRS 4:3 or 4 abnormal SIRS criteria. The SIRS criteria are defined as: heart rate > 52 bpm, respiratory rate > 20 bpm, temperature below or above 37.0–38.5°C, and WBC below or above 5.0‐12.5 × 109/L. From right to left on each day SIRS0, SIRS1/2, and SIRS 3/SIRS 4. The reference range is marked by a dotted horizontal line. A different letter indicates a significant difference between days (P < .05)

Table S1. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol ratio for survivors and nonsurvivors over 6 days of hospitalization

Table S2. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol for horses with and without SIRS over 6 days of hospitalization

Table S3. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol ratio for SIRS score categories (0‐4) over 6 days of hospitalization

Table S4. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol ratio for horses with no SIRS (0‐1 abnormal criteria); SIRS2: 2 abnormal SIRS criteria; SIRS 3/SIRS 4:3 or 4 abnormal SIRS criteria over 6 days of hospitalization

Table S5. Changes in the median [range] plasma ACTH and serum cortisol concentrations and the ACTH/cortisol for horses with and without an ischemic gastrointestinal lesion over 6 days of hospitalization


Articles from Journal of Veterinary Internal Medicine are provided here courtesy of Wiley

RESOURCES